chlorambucil has been researched along with formazans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bean, EA; Bentley, DP; Hanson, JA; Moore, JL; Nute, SR | 1 |
| Butters, TD; Ganeshaguru, K; Gerrard, G; Mehta, AB | 1 |
2 other study(ies) available for chlorambucil and formazans
| Article | Year |
|---|---|
In vitro chemosensitivity testing in chronic lymphocytic leukaemia patients.
Topics: Chlorambucil; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Stability; Formazans; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Tumor Cells, Cultured | 1991 |
Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Cell Line, Tumor; Chlorambucil; Cytotoxins; Enzyme Inhibitors; Female; Fluoresceins; Fluorescent Dyes; Formazans; Glucosyltransferases; Humans; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Models, Chemical; Molecular Structure; Tetrazolium Salts; Vidarabine | 2009 |